Cardiomyopathy

Cardiomyopathy is a term used to describe a group of diseases that affect the heart muscle. These conditions can make it harder for the heart to pump blood effectively, leading to various symptoms and potentially serious complications. Understanding the causes, symptoms, and stages of cardiomyopathy is crucial to ensuring proper management and treatment.

What is Cardiomyopathy?

Cardiomyopathy refers to a disease of the heart muscle that affects its ability to pump blood efficiently. This condition can cause the heart muscle to become enlarged, thickened, or stiffened, and in rare cases, it may lead to the formation of scar tissue. Cardiomyopathy leads to reduced ability of the heart to pump blood, which can result in symptoms such as fatigue, shortness of breath, and heart palpitations. If left untreated, cardiomyopathy can progress and lead to heart failure.

There are several types (Types | NHLBI, NIH, 2024) of cardiomyopathy, each with distinct characteristics and causes: 

• Dilated Cardiomyopathy: In this type, the heart becomes weak, and the chambers enlarge, making it difficult for the heart to pump enough blood to the body. Causes include idiopathic (unknown) factors, genetics, viral infections, and other medical conditions.
• Hypertrophic Cardiomyopathy: This type is characterised by a thickening of the heart muscle, making it harder for blood to leave the heart. It is typically inherited but can also be idiopathic (unknown).
• Arrhythmogenic Right Ventricular Dysplasia (ARVD): ARVD is a rare type of cardiomyopathy that primarily affects the right ventricle, leading to arrhythmias and an increased risk of sudden death. It is often caused by genetic mutations and is inherited.
• Restrictive Cardiomyopathy: In this type, the heart muscle becomes stiff, preventing proper filling of the heart chambers. Causes can include idiopathic factors, amyloidosis, and other diseases affecting the heart muscle.

The symptoms of cardiomyopathy can vary depending on the type and severity of the condition. Some common symptoms include:

• Fatigue: Individuals with cardiomyopathy may experience excessive tiredness and weakness due to the heart's reduced ability to pump blood effectively.
• Shortness of Breath: Shortness of breath may occur due to reduced cardiac output and fluid build-up in the lungs.
• Swelling (oedema): Fluid retention can occur in the legs, ankles, and feet, as well as in the abdomen and lungs, leading to swelling and discomfort.
• Chest Pain: Some individuals with cardiomyopathy may experience chest pain or pressure, particularly during physical exertion.
• Dizziness: Reduced blood flow to the brain can cause feelings of dizziness or lightheadedness, especially when standing up from a sitting or lying position.
• Palpitations: Patients may notice a rapid, pounding, or fluttering heartbeat, which can be a sign of arrhythmias associated with cardiomyopathy.

It is important to note that some individuals with cardiomyopathy may not experience any symptoms initially. As the condition progresses, the symptoms may become more apparent and severe.

Cardiomyopathy is a progressive condition that can be divided into four main stages:

• Early Stage: In the early stage of cardiomyopathy, patients may experience few or no symptoms. The heart muscle may show minimal changes, and the pumping function may still be relatively normal. At this stage, the focus is on identifying risk factors and implementing lifestyle modifications to prevent further progression of the disease.
• Symptomatic Stage: As cardiomyopathy progresses, patients may begin to experience symptoms such as shortness of breath, fatigue, and palpitations. The heart muscle may show more pronounced changes, and the pumping function may start to decline.
• Advanced Stage: In the severe stage of cardiomyopathy, patients may experience significant limitations in their daily activities due to worsening symptoms. The heart muscle may be significantly enlarged, thickened, or rigid, and the pumping function may be severely compromised.
• End-Stage: End-stage cardiomyopathy is characterised by severe heart failure and a significantly reduced quality of life. Patients may require frequent hospitalisations and may be considered for advanced therapies, such as heart transplantation or mechanical circulatory support.

Cardiomyopathy can develop due to various factors, some of which include:

• Genetic Factors: Some types of cardiomyopathy, such as hypertrophic cardiomyopathy, can be inherited through genetic mutations passed down from parents to children.
• High Blood Pressure: Untreated or poorly controlled hypertension can lead to the development of cardiomyopathy over time.
• Coronary Artery Disease: Damage to the heart muscle due to reduced blood flow or a heart attack can result in cardiomyopathy.
• Obesity: Being significantly overweight can put extra strain on the heart, increasing the risk of developing cardiomyopathy.
• Long-term Alcohol Misuse: Excessive alcohol consumption over an extended period can weaken the heart muscle and lead to alcohol-induced cardiomyopathy.
• Chemotherapy and Radiation Treatments: Some cancer treatments can have toxic effects on the heart, potentially leading to cardiomyopathy.
• Other Medical Conditions: Disorders such as diabetes, thyroid disease, hemochromatosis (iron overload), amyloidosis, and connective tissue disorders can increase the risk of developing cardiomyopathy.

In some cases, the exact cause of cardiomyopathy may remain unknown (idiopathic). Understanding the potential causes of cardiomyopathy can help individuals work with their doctors to develop appropriate treatment plans.

Several factors can increase the risk of developing cardiomyopathy, including (Causes and Risk Factors | NHLBI, NIH, 2024): 

• Age, as certain types of cardiomyopathy are more prevalent in specific age groups
• Family history of cardiomyopathy, heart failure, or sudden cardiac arrest (SCA)
• Underlying diseases or conditions that can lead to cardiomyopathy, such as coronary heart disease, heart attack, infections, and metabolic disorders
• Metabolic and hormonal disorders, including diabetes and obesity
• Diseases that can damage the heart, such as hemochromatosis, sarcoidosis, or amyloidosis
• Chemotherapy or radiation treatments for cancer
• Excessive alcohol consumption
• Uncontrolled high blood pressure
• Heart valve disorders
• Thyroid disease
• Long-term use of alcohol

Who's at Risk?

Individuals who are at a higher risk of developing cardiomyopathy include:

• Those with a family history of cardiomyopathy, heart failure, or sudden cardiac arrest
• People who have undergone chemotherapy or radiation treatments for cancer
• Individuals with diseases that can damage the heart, such as hemochromatosis, sarcoidosis, or amyloidosis
• Those with diabetes, obesity, or other metabolic and hormonal disorders
• People with uncontrolled high blood pressure

Understanding these risk factors can help individuals take proactive measures to prevent or manage cardiomyopathy.

If left untreated, cardiomyopathy can lead to several serious complications, such as:

• Heart Failure: As the heart muscle weakens, it may struggle to pump blood efficiently, leading to heart failure.
• Arrhythmias: Cardiomyopathy can cause irregular heart rhythms, which can potentially result in sudden cardiac death.
• Heart Valve Disorders: The condition can cause heart valves to malfunction, leading to further complications.
• Fluid Retention: Inefficient blood pumping may cause fluid to accumulate in the feet, ankles, legs, abdomen, or veins of the neck.
• Fatigue, Weakness, and Dizziness: These symptoms are common as the heart muscle weakens and struggles to maintain adequate circulation.
• Shortness of Breath: Cardiomyopathy can lead to respiratory distress due to insufficient blood oxygenation.

While not all cases of cardiomyopathy can be prevented, adopting a healthy lifestyle and managing underlying health conditions can significantly reduce the risk of developing the condition. Here are some of the preventative measures:

• Maintain a Healthy Diet: Eating a balanced diet low in saturated fats, trans fats, and sodium can help manage high blood pressure, diabetes, and obesity, which are risk factors for cardiomyopathy.
• Engage in Regular Exercise: Moderate physical activity can help maintain a healthy weight and improve overall heart function.
• Limit Alcohol Consumption: Excessive drinking can lead to heart damage, so keeping within these limits helps protect heart health.
• Avoid Smoking: Smoking cessation improves overall cardiovascular health by reducing damage to blood vessels and lowering the risk of heart disease and cardiomyopathy.
• Control High Blood Pressure: Regularly monitoring blood pressure and taking prescribed medications can help prevent heart damage.
• Manage Diabetes: Keeping blood sugar levels within a healthy range through diet, exercise, and medication can reduce the risk of cardiomyopathy.
• Treat Sleep Apnoea: Proper treatment of sleep apnoea helps reduce the strain on your heart and lowers the risk of developing cardiomyopathy.

By adopting these preventive measures, individuals can lower their risk of developing cardiomyopathy and maintain better overall heart health.

Diagnosing cardiomyopathy involves a comprehensive evaluation of an individual's medical history, physical examination, and various diagnostic tests. Some standard diagnostic methods include:

• Physical Examination: A doctor will assess the patient's general health, listen to their heart and lungs, and check for signs of fluid retention.
• Electrocardiogram (ECG): This non-invasive test records the heart's electrical activity, helping to detect abnormal heart rhythms and patterns suggestive of cardiomyopathy.
• Echocardiogram: An ultrasound of the heart, an echocardiogram provides detailed images of the heart's structure and function, allowing doctors to evaluate the heart's size, thickness, and pumping ability.
• Cardiac MRI: This advanced imaging technique offers a detailed view of the heart, helping to assess its structure, function, and any scarring or inflammation.
• Blood Tests: Various blood tests can help rule out other conditions that may cause similar symptoms and evaluate the presence of biomarkers indicative of heart failure.
• Stress Test: This test involves monitoring the heart's response to physical activity or medication-induced stress, helping to assess the heart's function under different conditions.
• Cardiac Catheterisation: In this invasive procedure, a thin tube is inserted into the heart through a blood vessel, allowing doctors to measure pressure within the heart chambers and collect blood samples.
• Genetic Testing: For individuals with a family history of cardiomyopathy, genetic testing may be recommended to identify specific mutations associated with the condition.

An accurate diagnosis of cardiomyopathy is essential for determining the most appropriate treatment plan and managing the condition effectively.

The management of cardiomyopathy involves a multifaceted approach that includes lifestyle modifications, medications, and surgical interventions. The primary goal is to alleviate symptoms, prevent further heart damage, and improve the overall quality of life for patients.

• Diet: Adopting a balanced diet with reduced salt and sugar intake is crucial for managing cardiomyopathy. This helps to prevent fluid retention and maintain a healthy weight.
• Exercise: Regular exercise, under the guidance of a healthcare professional, is essential for maintaining heart health and improving cardiovascular function.
• Weight Management: Maintaining a healthy weight reduces the strain on the heart, thereby preventing the progression of cardiomyopathy.
• Smoking Cessation: Quitting smoking is vital as it can exacerbate the condition and increase the risk of complications.
• Alcohol Moderation: Limiting alcohol consumption is advisable to prevent further damage to the heart muscle.
• Stress Management: Managing stress through relaxation techniques, such as meditation or yoga, can help reduce the burden on the heart.
• Medications: They may include heart failure medications, diuretics, and other medicines tailored to the specific needs of the patient. These medications aim to alleviate symptoms, prevent progression, and improve overall heart function.

Medication for Cardiomyopathy

Medications play a vital role in managing cardiomyopathy by improving heart function, controlling symptoms, preventing complications such as heart failure or arrhythmias, and enhancing quality of life. The choice of therapy depends on the type of cardiomyopathy (dilated, hypertrophic, restrictive, or arrhythmogenic right ventricular) and individual patient needs.

1. Beta-Blockers

These reduce heart rate, lower blood pressure, and decrease myocardial oxygen demand:

• Metoprolol: A cardioselective beta-blocker that reduces heart rate and myocardial oxygen demand, improving symptoms and survival in heart failure due to cardiomyopathy.
• Carvedilol: A non-selective beta and alpha-blocker that lowers blood pressure and improves left ventricular function in cardiomyopathy.
• Bisoprolol: Selectively blocks beta-1 receptors to reduce heart strain and improve long-term outcomes in systolic heart failure.
• Atenolol: A beta-1 selective blocker that helps control heart rate and reduce workload in hypertrophic cardiomyopathy and arrhythmias.
• Nebivolol: A beta-blocker with vasodilating properties, used to manage blood pressure and improve heart function in mild to moderate cardiomyopathy.

2. ACE Inhibitors

They help dilate blood vessels, lower blood pressure, and reduce strain on the heart:

• Enalapril: Reduces afterload and improves survival in patients with dilated cardiomyopathy and heart failure.
• Lisinopril: An ACE inhibitor that helps relax blood vessels and reduce heart remodelling in cardiomyopathy.
• Ramipril: Slows the progression of heart failure and improves symptoms by reducing ventricular stress.
• Perindopril: Enhances cardiac efficiency and lowers the risk of heart failure-related hospitalisation.
• Captopril: A short-acting ACE inhibitor used to quickly reduce blood pressure and heart workload in acute heart failure or cardiomyopathy.

3. Angiotensin II Receptor Blockers (ARBs)

Used when ACE inhibitors are not tolerated:

• Losartan: Blocks angiotensin II receptors to reduce afterload and prevent cardiac remodelling in patients intolerant to ACE inhibitors.
• Valsartan: Decreases blood pressure and improves heart function in cardiomyopathy, especially in patients with systolic dysfunction.
• Telmisartan: Provides long-acting blood pressure control and is beneficial in reducing cardiac fibrosis in cardiomyopathy.
• Olmesartan: Helps in managing hypertension and reducing cardiac strain in cardiomyopathy.

4. Angiotensin Receptor-Neprilysin Inhibitors (ARNIs)

Improves outcomes in heart failure with reduced ejection fraction (HFrEF):

• Sacubitril + valsartan: Combines neprilysin inhibition with ARB action to reduce heart failure progression and improve survival in cardiomyopathy with reduced ejection fraction.

5. Diuretics

Used to relieve symptoms of fluid overload, such as swelling and breathlessness:

• Furosemide: A loop diuretic that reduces fluid overload and relieves symptoms of breathlessness and oedema in heart failure.
• Torsemide: A longer-acting loop diuretic preferred in chronic management of volume overload in cardiomyopathy.
• Bumetanide: A potent loop diuretic used in resistant fluid retention associated with advanced cardiomyopathy.
• Hydrochlorothiazide: A thiazide diuretic used in combination with loop diuretics for enhanced fluid removal.
• Metolazone: A thiazide-like diuretic often used with loop diuretics for synergistic diuresis in refractory heart failure.

6. Mineralocorticoid Receptor Antagonists (MRAs)

Reduces morbidity and mortality in heart failure:

• Spironolactone: A potassium-sparing diuretic that reduces mortality in heart failure with reduced ejection fraction.
• Eplerenone: Selectively blocks aldosterone to prevent heart remodelling and reduce cardiovascular events in cardiomyopathy.

7. Anti-Arrhythmic Medications

Help control or prevent abnormal heart rhythms:

• Amiodarone: Controls life-threatening ventricular and atrial arrhythmias in cardiomyopathy patients.
• Sotalol: A beta-blocker and antiarrhythmic used to prevent recurrent arrhythmias in structural heart disease.
• Disopyramide: A Class IA antiarrhythmic used in hypertrophic cardiomyopathy to reduce outflow tract obstruction.

8. Anticoagulants

Prescribed to prevent blood clots, especially in atrial fibrillation or with a history of thromboembolism:

• Warfarin: A vitamin K antagonist used to prevent thromboembolic events in cardiomyopathy patients with atrial fibrillation or reduced ejection fraction.
• Apixaban: A direct factor Xa inhibitor used to reduce stroke risk in cardiomyopathy patients with atrial fibrillation.
• Rivaroxaban: An oral anticoagulant that prevents blood clots in cardiomyopathy patients at risk of stroke or systemic embolism.
• Dabigatran: A direct thrombin inhibitor used in patients with atrial fibrillation and cardiomyopathy to prevent clot formation.
• Edoxaban: Factor Xa inhibitor that lowers the risk of stroke in patients with non-valvular AF and cardiomyopathy.

9. Ivabradine

Used to reduce heart rate in patients with heart failure who are in sinus rhythm and cannot tolerate higher doses of beta-blockers.

10. Digoxin

Improves symptoms in selected patients with heart failure and atrial fibrillation by enhancing contractility and controlling heart rate.

11. Calcium Channel Blockers

Used cautiously in hypertrophic or restrictive cardiomyopathy for rate control and symptom relief:

• Verapamil: A non-dihydropyridine calcium channel blocker used to slow heart rate and reduce symptoms in hypertrophic cardiomyopathy.
• Diltiazem: Helps control heart rate and improves exercise tolerance in patients with hypertrophic or restrictive cardiomyopathy.

12. Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors

Recently approved for heart failure management regardless of diabetes status:

• Dapagliflozin: Originally used for diabetes, now proven to reduce hospitalisation and improve survival in heart failure with reduced ejection fraction.
• Empagliflozin: Offers cardiovascular protection and symptom relief in heart failure, including in non-diabetic cardiomyopathy patients.

If you experience symptoms such as shortness of breath, chest pain, palpitations, fainting, or swelling in the legs, ankles, or feet, it is essential to consult your doctor promptly. These symptoms may indicate cardiomyopathy or another serious heart condition. Early diagnosis and treatment can help manage symptoms and prevent complications. If you have a family history of cardiomyopathy or other heart diseases, discuss this with your doctor, as they may recommend regular check-ups and screenings.

• Cardiomyopathy is a group of diseases that affects the heart muscle, making it harder for the heart to pump blood effectively.
• There are several types of cardiomyopathy, including dilated, hypertrophic, restrictive, and arrhythmogenic right ventricular dysplasia.
• Symptoms of cardiomyopathy may include shortness of breath, fatigue, swelling in the legs and feet, chest pain, and palpitations.
• Diagnosis of cardiomyopathy involves a combination of medical history, physical examination, and diagnostic tests such as blood tests, imaging studies, and cardiac catheterisation.
• Management of cardiomyopathy includes lifestyle changes, medications, and in some cases, hospital procedures or heart transplantation.
• If you experience symptoms of cardiomyopathy or have a family history of the condition, it is essential to consult your doctor promptly for evaluation and appropriate management.